Betamethasone, neomycin
Sold as Bet-vet, Betnesol-n eye,ear and nose, Betnesol-n eye, Betanoid n
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 3
- Registrations
- 5
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Janssen Pharmaceutica (Pty) Ltd | Bet-vet | drops | 83/565 | Not determined | None |
| Glaxosmithkline South Africa (Pty) LimitedCertificate held by Adcock ingram limited | Betnesol-n eye,ear and nose, Betnesol-n eye | 100 mg, 350 mg / 100 ml, ointment | H1258, H1260 | S4 | PIPIL |
| Pharmacare limited û woodmeadCancelled | Betanoid n | ointment, cream | M0034, M0046 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Bet-vet drops EACH 100 ml CONTAINS BETAMETHASONE SODIUM PHOSPHATE A 100 mg NEOMYCIN SULPHATE A 350 mg | Drops | 83/565 | Old Medicine | Not determined | None |
| Betnesol-n eye,ear and nose drops EACH 100 ml CONTAINS BETAMETHASONE SODIUM PHOSPHATE A 0,1 g NEOMYCIN A 0,35 g | 100 mg, 350 mg / 100 mlSolution | H1258Approved 21 October 2022 | Old Medicine | S4 | PIPIL |
| Betnesol-n eye ointment EACH 100 g CONTAINS BETAMETHASONE SODIUM PHOSPHATE A 100 mg NEOMYCIN SULPHATE A EQUIVALENT TO 350 mg NEOMYCIN | Ointment | H1260 | Old Medicine | Not determined | None |
| Betanoid n ointment EACH 5 g OINTMENT CONTAINS BETAMETHASONE VALERATE EQUIVALENT TO 5 mg BETAMETHASONE NEOMYCIN SULPHATE 25 mg | Ointment | M0034M/13.4.1/34 | Cancelled | S4 | None |
| Betanoid n cream EACH 5 g CREAM CONTAINS BETAMETHASONE VALERATE EQUIVALENT TO 5 mg BETAMETHASONE NEOMYCIN SULPHATE 25 mg | Cream | M0046M/13.4.1/46 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Betamethasone sodium phosphate, neomycin
S4: Betamethasone
Consolidated Schedules 06 July 2026, line 5481
S4: Neomycin
- except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 7224 to 7225
S3: Sodium phosphate
- in preparations intended for the management of faecal impaction or for bowel cleansing prior to surgical and diagnostic procedures. (S0)
Consolidated Schedules 06 July 2026, lines 4251 to 4252
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Betnesol-n eye,ear and nose drops, Glaxosmithkline South Africa (Pty) Limited is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.